News

Molecular Partners’ strategic partner Allergan announces that EMA has validated the marketing authorisation application for abicipar

Molecular Partners’ strategic partner Allergan announces that EMA has validated the marketing authorisation application for abicipar CAESAREA, Israel, Aug. 15, 2019 — V-Wave Ltd., a privately held medical device company developing novel implantable interatrial shunt devices, today announced that the U.S. Food and Drug Administration (FDA) has just granted [...]

2019-10-10T09:43:07+01:00August 7th, 2019|All News, Company News, Previous Sectors|

Interview with Rob Barmann, Senior Investment Director at Endeavour Vision

Interview with Rob Barmann, Senior Investment Director at Endeavour Vision Previously Vice President, Corporate Business Development at Boston Scientific. Rob, you joined Endeavour Vision after 15 years working at Boston Scientific, can you summarise your role there? My job was to assess and execute business development transactions including acquisitions, [...]

2019-10-10T09:41:58+01:00July 24th, 2019|All News, Blog|

Interview with Kevin Hykes, President & CEO at Relievant

Interview with Kevin Hykes, President & CEO at Relievant Can you tell us a bit about Relievant Medsystems and the Intracept® Procedure? Relievant is a venture-backed medical device company founded in 2006, based in Minneapolis and Sunnydale, California with around 45 employees. Our focus is currently shifting from [...]

2019-10-11T12:08:28+01:00June 12th, 2019|All News, Blog|

CeQur appoints Bradley Paddock Chief Executive Officer

CeQur appoints Bradley Paddock Chief Executive Officer Medical Device Veteran Has 23-Year Record of Successful Commercial and Organizational Leadership MARLBOROUGH, Mass., June 5, 2019 — CeQur® announced that the company has appointed Bradley Paddock as chief executive officer, effective today. Paddock brings a track record of commercial medtech successes, [...]

2019-10-10T09:39:28+01:00June 6th, 2019|All News, Blog|

Interview with Chris Owens, CEO & President at Gynesonics, Inc

Interview with Chris Owens, CEO & President at Gynesonics, Inc What is Gynesonics about? How are you changing the standard of care in uterine fibroids? Gynesonics is focused on advancing women’s health by developing uterus-preserving, incision free, transcervical technology. Currently, we are focused on the treatment of symptomatic [...]

2019-10-11T12:11:54+01:00May 24th, 2019|All News, Blog|

Boston Scientific Announces Agreement to Acquire Vertiflex, Inc.

Boston Scientific Announces Agreement to Acquire Vertiflex, Inc. Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies. Vertiflex has raised approximately $160 million in funding from investors including Endeavour Vision, NEA and H.I.G. BioVentures. MARLBOROUGH, Mass., May 9, 2019 / — Boston Scientific (NYSE: [...]

2019-10-10T09:38:12+01:00May 9th, 2019|All News, Company News|

Nuvaira receives french innovation funding for Nuvaira Airflow-3 pivotal trail

Nuvaira receives french innovation funding for Nuvaira Airflow-3 pivotal trail Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies. Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, April 28, 2018 – Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, [...]

2019-10-10T09:37:34+01:00May 6th, 2019|All News, Company News|

Relievant announces publication of SMART trial 24-month results

Relievant announces publication of SMART trial 24-month results Intracept® Procedure Demonstrates Durable Results at 24 Months. MINNEAPOLIS – April 24, 2019 – Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), today announced the publication of 24-month results from the SMART [...]

2019-10-10T09:35:57+01:00April 28th, 2019|All News, Company News|

Sophia genetics achieves CE-IVD milestone

Sophia genetics achieves CE-IVD milestone for its Solid Tumor Solution for accurate cancer detection. Lausanne, SWITZERLAND – 11 April 2019: SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today the CE-IVD marking of its Solid Tumor Solution (STS), a new step in the fight against cancer. This standardized [...]

2019-10-10T09:34:51+01:00April 11th, 2019|All News, Company News|

William T. Abraham, Md Joins V-wave as Chief Medical Officer

William T. Abraham, Md Joins V-wave as Chief Medical Officer CAESAREA, Israel, March 11, 2019 – V-Wave Ltd., an early stage medtech company, developing an implantable interatrial shunt device for treating advanced heart failure (HF) and pulmonary arterial hypertension (PAH), announced today that renowned heart failure cardiologist, William T. [...]

2019-10-10T09:33:50+01:00March 11th, 2019|All News, Company News|